Peeters Robin P, van der Deure Wendy M, Visser Theo J
Department of Internal Medicine, Erasmus University Medical Center, Dr Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
Eur J Endocrinol. 2006 Nov;155(5):655-62. doi: 10.1530/eje.1.02279.
Serum thyroid parameters show substantial inter-individual variability, in which genetic variation is a major factor. Findings in patients with subclinical hyper- and hypothyroidism illustrate that even minor alterations in serum thyroid function tests can have important consequences for a variety of thyroid hormone-related clinical endpoints, such as atherosclerosis, bone mineral density, obesity, and heart rate. In the last few years, several studies described polymorphisms in thyroid hormone pathway genes that alter serum thyroid function tests. In this review, we discuss the genetic variation in the TSH receptor and iodothyronine deiodinases. We discuss the possible consequences of these studies for the individual patient and also the new insights in thyroid hormone action that can be obtained from these data.
血清甲状腺参数显示出个体间的显著差异,其中遗传变异是一个主要因素。亚临床甲状腺功能亢进和减退患者的研究结果表明,即使血清甲状腺功能测试中的微小变化也可能对多种甲状腺激素相关的临床终点产生重要影响,如动脉粥样硬化、骨密度、肥胖和心率。在过去几年中,多项研究描述了甲状腺激素途径基因中的多态性,这些多态性会改变血清甲状腺功能测试结果。在本综述中,我们讨论促甲状腺激素受体和碘甲状腺原氨酸脱碘酶的遗传变异。我们讨论这些研究对个体患者可能产生的后果,以及从这些数据中可以获得的甲状腺激素作用的新见解。